|
|
| | Deoxy-thalidomide-Pip-C-PIP-boc Basic information |
| Product Name: | Deoxy-thalidomide-Pip-C-PIP-boc | | Synonyms: | Deoxy-thalidomide-Pip-C-PIP-boc;1-Piperazinecarboxylic acid, 4-[[1-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-4-piperidinyl]methyl]-, 1,1-dimethylethyl ester | | CAS: | 2963655-14-1 | | MF: | C28H39N5O5 | | MW: | 525.64 | | EINECS: | | | Product Categories: | | | Mol File: | 2963655-14-1.mol |  |
| | Deoxy-thalidomide-Pip-C-PIP-boc Chemical Properties |
| Boiling point | 743.1±60.0 °C(predicted) | | density | 1.260±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 10.83±0.40(predicted) |
| | Deoxy-thalidomide-Pip-C-PIP-boc Usage And Synthesis |
| Uses | Deoxy-thalidomide-Pip-C-PIP-boc is a conjugate of E3 ligase ligand and linker, consisting of Thalidomide (HY-14658) and the corresponding Linker. Deoxy-thalidomide-Pip-C-PIP-boc can serve as a Cereblon ligand to recruit CRBN protein and serve as a key intermediate for the synthesis of complete PROTAC molecules. | | References | [1] Fischer ES, et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014 Aug 7;512(7512):49-53. DOI:10.1038/nature13527
[2] Sun X, et al. Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling. Med Sci Monit. 2018 May 15;24:3193-3203. DOI:10.12659/MSM.909977
[3] Bian C, et al. Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-β/Smad3 signaling pathway in an Nrf2-dependent manner. Free Radic Biol Med. 2018 Dec;129:446-453. DOI:10.1016/j.freeradbiomed.2018.10.423 |
| | Deoxy-thalidomide-Pip-C-PIP-boc Preparation Products And Raw materials |
|